Theralase Technologies Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	69	44	66	40	69	77
Market Cap Growth	53.91%	-33.43%	64.23%	-42.29%	-9.56%	97.37%
Enterprise Value	69	44	66	40	67	72
Last Close Price	0.23	0.17	0.27	0.17	0.32	0.38
PS Ratio	80.99	53.54	63.54	37.35	60.85	98.13
PB Ratio	35.64	24.59	31.76	20.98	22.40	15.11
P/TBV Ratio	35.64	24.59	31.76	20.98	22.40	15.11
EV/Sales Ratio	80.32	53.83	63.53	37.52	59.13	91.82
Debt / Equity Ratio	0.22	0.26	0.14	0.20	0.15	0.01
Net Debt / Equity Ratio	-0.29	0.16	0.01	0.18	-0.33	-0.72
Net Debt / EBITDA Ratio	0.16	-0.07	-0.01	-0.08	0.21	0.85
Net Debt / FCF Ratio	0.18	-0.08	-0.01	-0.08	0.20	0.89
Asset Turnover	0.25	0.24	0.32	0.29	0.23	0.10
Inventory Turnover	0.60	0.59	0.80	0.89	0.97	0.92
Quick Ratio	1.01	0.85	0.99	0.60	2.86	4.56
Current Ratio	1.37	1.25	1.61	1.39	3.67	5.71
Return on Equity (ROE)	-242.19%	-214.33%	-214.26%	-182.91%	-128.27%	-61.98%
Return on Assets (ROA)	-67.86%	-77.42%	-82.17%	-77.21%	-64.71%	-35.56%
Return on Capital Employed (ROCE)	-182.00%	-223.10%	-189.70%	-208.90%	-150.40%	-89.60%
Earnings Yield	-5.30%	-9.43%	-6.48%	-11.43%	-7.56%	-5.76%
FCF Yield	-4.55%	-7.63%	-5.13%	-10.28%	-7.47%	-5.39%
Buyback Yield / Dilution	-5.24%	-5.44%	-9.14%	-5.79%	-1.79%	-